Preimplantation Genetic Testing Market Size, Share, and Growth Forecast 2026 – 2033

The global preimplantation genetic testing market size is expected to be valued at US$ 598.4 million in 2026 and is projected to reach US$ 1,081.9 million by 2033, growing at a CAGR of 8.8% between 2026 and 2033.

The preimplantation genetic testing (PGT) market is experiencing steady growth, driven by the rising prevalence of genetic disorders and increased adoption of in vitro fertilization (IVF) procedures. Technological advancements, such as next-generation sequencing and improved embryo biopsy techniques, have enhanced test accuracy and reliability. Growing awareness among the parents about hereditary diseases and increasing maternal age are also fueling demand. Supportive regulatory frameworks and improved healthcare infrastructure, especially in developed regions, further contribute to market expansion. Additionally, the availability of user-friendly testing kits and automated platforms is streamlining clinical workflows, making PGT more accessible and efficient in fertility treatments.